Idexx Laboratories (IDXX) Shares Cross Below 200 DMA Thursday, September 7, 4:18 PM ET, by Market News Video Staff In trading on Thursday, shares of Idexx Laboratories, Inc. (IDXX) crossed below their 200 day ...
Idexx Laboratories Becomes Oversold (IDXX) Friday, September 8, 11:59 AM ET, by Market News Video Staff Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
RSI Alert: Idexx Laboratories (IDXX) Now Oversold Tuesday, October 3, 4:11 PM ET, by Market News Video Staff Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
How The Parts Add Up: ESGU Headed For $112 Thursday, October 5, 7:05 AM ET, by Market News Video Staff Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...
Noteworthy Tuesday Option Activity: WBD, IDXX, BAC Tuesday, October 10, 1:19 PM ET, by Market News Video Staff Looking at options trading activity among components of the S&P 500 index, there is noteworthy ...
Agree To Buy Idexx Laboratories At $490, Earn 7.2% Annualized Using Options
By Market News Video Staff, Monday, December 20, 2:14 PM ET
Investors considering a purchase of Idexx Laboratories, Inc. (NASDAQ:IDXX) shares, but cautious about paying the going market price of $602.96/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December 2022 put at the $490 strike, which has a bid at the time of this writing of $34.70. Collecting that bid as the premium represents a 7.1% return against the $490 commitment, or a 7.2% annualized rate of return (at Stock Options Channel we call this the YieldBoost).
Selling a put does not give an investor access to IDXX's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $490 strike if doing so produced a better outcome than selling at the going market price. (Do options carry counterparty risk? This and six other common options myths debunked). So unless Idexx Laboratories, Inc. sees its shares decline 18.1% and the contract is exercised (resulting in a cost basis of $455.30 per share before broker commissions, subtracting the $34.70 from $490), the only upside to the put seller is from collecting that premium for the 7.2% annualized rate of return.
Below is a chart showing the trailing twelve month trading history for Idexx Laboratories, Inc., and highlighting in green where the $490 strike is located relative to that history:
The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the December 2022 put at the $490 strike for the 7.2% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Idexx Laboratories, Inc. (considering the last 251 trading day closing values as well as today's price of $602.96) to be 27%. For other put options contract ideas at the various different available expirations, visit the IDXX Stock Options page of StockOptionsChannel.com.
This Article's Word Cloud:ArialBelowChannelCollectingDecemberIDXXIdexxInvestorsLaboratoriesNasdaqOptionsPutsSellingStockYieldBoostannualizedbenefitchartconsideringcontractexercisedfillColorfromgoinghistorymarketmonthonlyoptionsotherowningpremiumpriceraterepresentsreturnsellersellingsharesharesstrikethatthistradingtrailingtwelveupsidevolatilitywherewould
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.